In addition, experiments have confirmed that more than 70 cases of MEG3 are significantly down-regulated in human HCC and found that low levels of MEG3 are associated with adverse clinical reactions of HCC, resulting in reduced overall survival and recurrence-free survival [25]. The gene discussed is MEG3; the disease is hepatocellular carcinoma.